SEC 13F Intelligence

Ferguson Wellman Capital Management, Inc / ABBV

Ferguson Wellman Capital Management, Inc’s Abbvie Inc Position

Does Ferguson Wellman Capital Management, Inc own Abbvie Inc (ABBV)? Yes650.4K shares worth $141M (+1.93% of its 13F portfolio) as of Q1 2026, down from 650.5K shares the prior filed quarter.

Position Value
$141M
Q1 2026
Shares
650.4K
% of Portfolio
+1.93%
Quarters Held
30
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $75MQ4 ’18Q1 ’19: $22MQ2 ’19: $36MQ3 ’19: $40MQ4 ’19: $48MQ4 ’19Q1 ’20: $50MQ2 ’20: $65MQ3 ’20: $68MQ4 ’20: $84MQ4 ’20Q1 ’21: $53MQ2 ’21: $54MQ3 ’21: $52MQ4 ’21: $68MQ4 ’21Q1 ’22: $80MQ2 ’22: $60MQ3 ’22: $43MQ4 ’22: $96,748Q4 ’22Q1 ’23: $94MQ2 ’23: $80MQ3 ’23: $82MQ4 ’23: $85MQ4 ’23Q1 ’24: $119MQ2 ’24: $109MQ3 ’24: $125MQ4 ’24: $112MQ4 ’24Q1 ’25: $134MQ2 ’25: $120MQ3 ’25: $150MQ4 ’25: $149MQ4 ’25Q1 ’26: $141Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026650.4K$141M+1.93%
Q4 2025650.5K$149M+2.38%
Q3 2025647.7K$150M+2.43%
Q2 2025644.4K$120M+2.11%
Q1 2025639.3K$134M+2.60%
Q4 2024628.2K$112M+2.12%
Q3 2024633.7K$125M+2.42%
Q2 2024636.6K$109M+2.22%
Q1 2024651.8K$119M+2.42%
Q4 2023549.4K$85M+1.91%
Q3 2023548.9K$82M+2.00%
Q2 2023591.9K$80M+1.87%
Q1 2023592.0K$94M+2.37%
Q4 2022598.6K$96,748+2.52%
Q3 2022319.9K$43M+1.68%
Q2 2022393.8K$60M+2.24%
Q1 2022491.9K$80M+2.51%
Q4 2021499.4K$68M+1.97%
Q3 2021486.3K$52M+1.69%
Q2 2021482.3K$54M+1.77%
Q1 2021492.7K$53M+1.85%
Q4 2020785.3K$84M+2.06%
Q3 2020776.1K$68M+1.87%
Q2 2020663.4K$65M+1.99%
Q1 2020651.9K$50M+1.86%
Q4 2019539.1K$48M+1.41%
Q3 2019529.4K$40M+1.28%
Q2 2019489.6K$36M+1.18%
Q1 2019276.6K$22M+0.76%
Q4 2018813.1K$75M+2.88%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ferguson Wellman Capital Management, Inc’s full portfolio or all institutional holders of ABBV.